Literature DB >> 25313192

Response to "Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics".

Charles Cobbs1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25313192      PMCID： PMC4201079          DOI： 10.1093/neuonc/nou295

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  21 in total

1.  Human cytomegalovirus and primary intracranial tumours: frequency of tumour infection and lack of correlation with systemic immune anti-viral responses.

Authors:  E Bianchi; P Roncarati; O Hougrand; V Guérin-El Khourouj; R Boreux; J Kroonen; D Martin; P Robe; B Rogister; P Delvenne; M Deprez
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

2.  Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics.

Authors:  T Ogura; J Tanaka; S Kamiya; H Sato; H Ogura; M Hatano
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

3.  Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma.

Authors:  Andrea Schuessler; Corey Smith; Leone Beagley; Glen M Boyle; Sweera Rehan; Katherine Matthews; Linda Jones; Tania Crough; Vijayendra Dasari; Kerenaftali Klein; Amy Smalley; Hamish Alexander; David G Walker; Rajiv Khanna
Journal:  Cancer Res       Date:  2014-05-04       Impact factor: 12.701

4.  Cytomegalovirus in the brain: in vitro infection of human brain-derived cells.

Authors:  S D Poland; P Costello; G A Dekaban; G P Rice
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

5.  Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

Authors:  G Pauletti; W Godolphin; M F Press; D J Slamon
Journal:  Oncogene       Date:  1996-07-04       Impact factor: 9.867

6.  Lack of association of cytomegalovirus with human brain tumors.

Authors:  Sean K Lau; Yuan-Yuan Chen; Wen-Gang Chen; Don J Diamond; Adam N Mamelak; John A Zaia; Lawrence M Weiss
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

7.  The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation.

Authors:  S D Poland; L L Bambrick; G A Dekaban; G P Rice
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

8.  Detection of human cytomegalovirus in different histological types of gliomas.

Authors:  Michael E Scheurer; Melissa L Bondy; Kenneth D Aldape; Thomas Albrecht; Randa El-Zein
Journal:  Acta Neuropathol       Date:  2008-03-20       Impact factor: 17.088

9.  Cytomegalovirus infection of cerebral astrocytoma in an AIDS patient.

Authors:  K L Ho; C Gottlieb; R J Zarbo
Journal:  Clin Neuropathol       Date:  1991 May-Jun       Impact factor: 1.368

10.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701
View more
  9 in total

1.  Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples.

Authors:  Marie-Pierre Loit; Homa Adle-Biassette; Schahrazed Bouazza; Marie-Christine Mazeron; Philippe Manivet; Jacqueline Lehmann-Che; Natacha Teissier; Emmanuel Mandonnet; Jean-Michel Molina
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

2.  No circulating human cytomegalovirus in 14 cases of glioblastoma.

Authors:  Steven Lehrer; Sheryl Green; Kenneth E Rosenzweig; Angela Rendo
Journal:  Neuro Oncol       Date:  2014-12-01       Impact factor: 12.300

3.  Towards an unbiased, collaborative effort to reach evidence about the presence of human cytomegalovirus in glioblastoma (and other tumors).

Authors:  Martin Michaelis; Michel Mittelbronn; Jindrich Cinatl
Journal:  Neuro Oncol       Date:  2015-07       Impact factor: 12.300

4.  No evidence for human cytomegalovirus infection in pediatric medulloblastomas.

Authors:  Jeroen F Vermeulen; Wim van Hecke; Mieke K Jansen; Wim G M Spliet; Roel Broekhuizen; Niels Bovenschen
Journal:  Neuro Oncol       Date:  2016-08-12       Impact factor: 12.300

Review 5.  Cytomegalovirus and glioblastoma; controversies and opportunities.

Authors:  Sean E Lawler
Journal:  J Neurooncol       Date:  2015-02-15       Impact factor: 4.130

6.  The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties.

Authors:  Jeffrey R van Senten; Maarten P Bebelman; Tian Shu Fan; Raimond Heukers; Nick D Bergkamp; Puck van Gasselt; Ellen V Langemeijer; Erik Slinger; Tonny Lagerweij; Afsar Rahbar; Marijke Stigter-van Walsum; David Maussang; Rob Leurs; René J P Musters; Guus A M S van Dongen; Cecilia Söderberg-Nauclér; Thomas Würdinger; Marco Siderius; Martine J Smit
Journal:  J Biol Chem       Date:  2019-09-13       Impact factor: 5.157

7.  Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization.

Authors:  Matthias Holdhoff; Gunes Guner; Fausto J Rodriguez; Jessica L Hicks; Qizhi Zheng; Michael S Forman; Xiaobu Ye; Stuart A Grossman; Alan K Meeker; Christopher M Heaphy; Charles G Eberhart; Angelo M De Marzo; Ravit Arav-Boger
Journal:  Clin Cancer Res       Date:  2016-12-29       Impact factor: 12.531

8.  The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth.

Authors:  Raimond Heukers; Tian Shu Fan; Raymond H de Wit; Jeffrey R van Senten; Timo W M De Groof; Maarten P Bebelman; Tonny Lagerweij; Joao Vieira; Sabrina M de Munnik; Laura Smits-de Vries; Jody van Offenbeek; Afsar Rahbar; Diane van Hoorick; Cecilia Söderberg-Naucler; Thomas Würdinger; Rob Leurs; Marco Siderius; Henry F Vischer; Martine J Smit
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

Review 9.  The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.

Authors:  Abigail Morales-Sánchez; Ezequiel M Fuentes-Panana
Journal:  Cancers (Basel)       Date:  2018-03-30       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.